Enhabit, Inc. (NYSE:EHAB – Get Free Report) has been given an average rating of “Moderate Buy” by the eight research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $12.10.
A number of research analysts have recently commented on EHAB shares. Truist Financial set a $10.50 price objective on shares of Enhabit and gave the company a “hold” rating in a research report on Wednesday, January 7th. UBS Group upgraded Enhabit from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $8.50 to $12.00 in a report on Thursday, January 8th. Citigroup restated a “buy” rating on shares of Enhabit in a research note on Tuesday, December 16th. TD Cowen raised Enhabit to a “buy” rating in a research report on Tuesday, January 13th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th.
Check Out Our Latest Report on EHAB
Enhabit Trading Up 0.6%
Hedge Funds Weigh In On Enhabit
Several institutional investors and hedge funds have recently modified their holdings of EHAB. Bailard Inc. acquired a new position in Enhabit during the third quarter worth $442,000. Phocas Financial Corp. acquired a new position in shares of Enhabit during the second quarter valued at about $3,094,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of Enhabit during the second quarter worth about $717,000. Globeflex Capital L P bought a new stake in shares of Enhabit during the second quarter worth about $1,154,000. Finally, Campbell & CO Investment Adviser LLC acquired a new stake in shares of Enhabit in the 2nd quarter worth about $958,000.
Enhabit Company Profile
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Featured Stories
- Five stocks we like better than Enhabit
- Trump’s Hand-Written Letter Will Shock his Haters
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
